UnitedHealth's medical care ratio drops to 88.4% as Medicare Advantage rolls shrink
UnitedHealth Group's third-quarter medical care ratio fell to 88.4% from 89.9%, and it raised its 2026 adjusted EPS outlook to at least $20.50, even as its Medicare Advantage senior count is down 935,000 since the end of 2025.

UnitedHealth Group is covering fewer people and earning more on the ones it keeps.
The company said Oct. 13 that its medical care ratio, the share of premium revenue spent on members' medical care, fell to 88.4% in the third quarter from 89.9% a year earlier. It raised its full-year 2026 outlook to adjusted earnings of at least $20.50 a share and GAAP earnings of at least $19.50, according to its earnings release.
Why it matters: UnitedHealth credited the lower ratio to medical cost management, changes in benefit design, pricing discipline and changes in how it delivers care, and UnitedHealthcare's operating margin widened to 3.3% from 2.1%. At the same time, the company said the number of seniors it serves through Medicare Advantage, including programs for complex populations in Medicaid, has fallen by 935,000 since the end of 2025.
Revenue was $112.7 billion, compared with $113.2 billion a year earlier. Earnings from operations rose to $6.6 billion from $4.3 billion, though they were below the second quarter's $8.0 billion. Net margin was 3.6%. The company reported earnings of $4.56 a share and adjusted earnings of $4.69.
The quarter included $610 million of net favorable reserve development tied to 2026 dates of service, meaning medical costs from earlier in the year came in below what the company had set aside. The operating cost ratio was 12.8%, compared with 13.5%.
Smaller membership, wider margins
UnitedHealthcare served 48.3 million people and posted revenue of $86.3 billion, down from $87.1 billion, while its earnings from operations rose to $2.8 billion from $1.8 billion. Revenue in its Medicare and retirement business fell to $42.4 billion from $43.4 billion, which the company attributed to shifts in membership and product mix.
Other lines shrank too. Employer and individual membership declined by 165,000 in the quarter because of employer attrition, and community and state membership fell by 85,000 because of Medicaid eligibility changes, the company said.
UnitedHealthcare said at least 69% of its Medicare Advantage members are in plans rated four stars or higher for 2027, which it called in line with expectations. In CMS's 2027 Star Ratings, released five days earlier, about 71% of enrollees in Medicare Advantage drug contracts were in contracts rated four stars or more.
Optum revenue was $66.9 billion, compared with $69.2 billion, while its operating earnings rose to $3.7 billion from $2.5 billion. Optum Health revenue fell 10% to $22.9 billion, which the company attributed to serving fewer patients under value-based care in markets where it lacked the scale to support its clinicians. Optum Health's operating earnings were $735 million, compared with $41 million a year earlier.
Optum Insight revenue rose 3% to $5.5 billion. Optum Rx revenue was $39.9 billion, and adjusted scripts fell to 393 million from 414 million, which the company tied to membership declines at UnitedHealthcare and other customers.
"Our third quarter results reflect the discipline and execution our teams are bringing to every part of our business," Stephen Hemsley, chief executive, said in the release.
What comes next
The release restated commitments aimed at clinicians and pharmacy clients and said more are expected in 2027. UnitedHealth said it plans to cut its current prior approval volume by 30% by the end of 2026 and expects a standardized electronic submission effort to cover more than 70% of UnitedHealthcare's prior approvals by then. It has also committed to pass all manufacturer drug rebate discounts through to clients by Jan. 1, 2028.
The company also said it is still targeting a long-term debt-to-capital ratio of about 40% by year-end, compared with 41.7% at Sept. 30.



